Karolinska Institutet
Stockholm, Karolinska Institutet, 17177, Sweden
Location status: Recruiting
Location contact
Maria Lalouni, PhD
CONTACT
Viktor Vadenmark, MSc
CONTACT
NCT Number: NCT05945251
Functional abdominal pain disorders (FAPDs) in children are common (14%) and abdominal pain has increased rapidly in children during the last ten years in Sweden. Many children with FAPDs have low quality of life, missed school days, and about 30-40% suffer from psychiatric comorbidity. FAPDs are often sustained into adulthood and a large Swedish cohort study showed that abdominal pain during childhood is an independent strong predictor anxiety and depression later in life. Internet-cognitive behavioral therapy (Internet-CBT) can improve FAPD symptoms, but a significant number of children does not respond to the treatment.
We will here determine the pain regulation in children with FAPDs, compared with healthy controls, and assess:
What aspects of the child's pain regulation is related to improvement for children with FAPDs engaging in Internet-CBT?
Does some aspects of the child's pain regulation change during treatment?
Interested in participating?
Request Info8 year–17 year
All sexes
Observational
Stockholm, Karolinska Institutet, 17177, Sweden
Location status: Recruiting
Maria Lalouni, PhD
CONTACT
Viktor Vadenmark, MSc
CONTACT
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Children 8-17 years with FAPDs: Have been offered treatment at BUP Internetbehandling for FAPDs.
Children 8-17 years without FAPDs: Not affected by recurrent (every week) or persistant pain during the last year.
Exclusion criteria
Contraindication for MR (metal implant or metal object in body, claustrophobia, pregnancy)
Ten weekly modules for children and ten weekly modules for parents. Exposure-based cognitive behavioral therapy delivered online with asynchronous support via text messages from psychologists.
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Algometer pressure (in kPa) for the pain threshold
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Children rate their unpleasantness on a scale 0-10
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Algometer pressure (in kPa) for the pain threshold
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Children rate their unpleasantness on a scale 0-10
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Conditioned pain: hand in 10°C cold water, test pain: presseure pain thresholds by algometer on the participant's thigh. Difference in pressure pain thresholds with and without the simultaneous conditioned stimuli
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Pinprick stimuli of low pain, one time, then repeated 10 times. Pain after repeated stimulus minus pain for the single stimulus.
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Pressure pain thresholds (kPa) applied by the child or the experimenter. Sensory attenuation = difference in pain threshold between self-induced and experimenter induced
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Differences in network connectivity (Yeo networks + subcortical areas) and between seed (trunk in the somatosensory cortex) to Yeo brain networks + subcortical areas).
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Differences in network connectivity (Yeo networks + subcortical areas) and between seed (trunk in the somatosensory cortex) to Yeo brain networks + subcortical areas).
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Self-assessed questionnaire of abdominal symptoms
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Self-assessed questionnaire of pain intensity
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Self-assessed questionnaire of gastrointestinal-specific anxiety
Time frame: Baseline differences and baseline to follow-up after 10 week's treatment (or 10 week's wait for healthy children)
Self-assessed questionnaire of gastrointestinal-specific avoidance and controlling behaviors
Contact information is provided by the study sponsor or research team.
Maria Lalouni, PhD
CONTACT
Viktor Vadenmark, MSc
CONTACT
Karolinska Institutet
Other
Individualized Online Cognitive Behavioral Therapy for Children With Functional Abdominal Pain Disorders - the Child's Pain Regulation
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05814497
Autonomic Nervous System Diseases, Chronic Pain
Cincinnati, Ohio, United States
View Trial DetailsNCT06315179
Anorectal Disorder, Bile Duct Diseases
Seattle, Washington, United States
View Trial DetailsNCT06268964
Digestive System Diseases, Functional Abdominal Pain Syndrome
Colima, Mexico
View Trial DetailsNCT06481072
Functional Abdominal Pain Syndrome
Gothenburg, Sweden
View Trial Details